Review
Open access
Oct 2026
Optimizing early identification and management of trastuzumab deruxtecan-related interstitial lung disease: insights from a multidisciplinary expert panel
Proactive surveillance strategies are essential to minimize ILD-related morbidity while preserving access to T-DXd therapy and the implementation of standardized clinical pathways and the development of biomarker-driven approaches may further improve personalized ILD risk management.
L. Licata, C. Lisanti, G. Arpino et al.
· Frontiers in Oncology · 0 citations